Consilium Wealth Advisory’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$542K Buy
3,754
+558
+17% +$84.6K 0.19% 69
2025
Q4
$458K Hold
3,196
0.17% 69
2025
Q3
$491K Buy
3,196
+100
+3% +$15.6K 0.19% 70
2025
Q2
$493K Hold
3,096
0.21% 66
2025
Q1
$528K Buy
3,096
+96
+3% +$16.1K 0.26% 56
2024
Q4
$503K Hold
3,000
0.24% 59
2024
Q3
$520K Hold
3,000
0.28% 56
2024
Q2
$495K Hold
3,000
0.27% 57
2024
Q1
$487K Hold
3,000
0.27% 58
2023
Q4
$440K Hold
3,000
0.26% 60
2023
Q3
$438K Hold
3,000
0.31% 57
2023
Q2
$455K Hold
3,000
0.32% 57
2023
Q1
$446K Hold
3,000
0.38% 53
2022
Q4
$455K Hold
3,000
0.39% 52
2022
Q3
$379K Sell
3,000
-52
-2% -$7.39K 0.42% 52
2022
Q2
$439K Hold
3,052
0.47% 55
2022
Q1
$466K Buy
3,052
+10
+0.3% +$1.56K 0.33% 60
2021
Q4
$498K Buy
+3,042
New +$452K 0.32% 62

Other funds holding PG

Consilium Wealth Advisory's PG Position: Q1 2026 in Review

Consilium Wealth Advisory increased its Procter & Gamble (PG) stake by 17% in Q1 2026, buying an estimated $84.6K and bringing the position to 3,754 shares worth $542K. The position accounts for 0.19% of the portfolio, ranked #69.

Consilium Wealth Advisory first reported a position in PG in Q4 2021 and has held it in 18 quarters since. 3,987 funds tracked by Wall St. Rank hold PG as of Q1 2026.

  • Consilium Wealth Advisory held 3,754 shares of Procter & Gamble worth $542K as of Q1 2026.
  • Consilium Wealth Advisory bought 558 Procter & Gamble shares in Q1 2026, an estimated $84.6K.
  • Procter & Gamble made up 0.19% of Consilium Wealth Advisory's portfolio in Q1 2026, its #69 holding.
  • Consilium Wealth Advisory first reported a position in Procter & Gamble in Q4 2021 and has held it in 18 quarters since.
  • 3,987 funds tracked by Wall St. Rank held Procter & Gamble as of Q1 2026.

Based on Consilium Wealth Advisory's 13F filing for Q1 2026, filed 20 Apr 2026.